Morgan Stanley
LBRX icon

Morgan Stanley’s LB Pharmaceuticals LBRX Stock Holding History

Morgan Stanley’s Portfolio LBRX Stock Details LBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
51,207
+3,927
+8% +$115K ﹤0.01% 4946
2026
Q1 		$1.17M Buy
47,280
+22,639
+92% +$522K ﹤0.01% 5059
2025
Q4 		$549K Buy
24,641
+15,036
+157% +$263K ﹤0.01% 5460
2025
Q3 		$152K Buy
+9,605
New +$152K ﹤0.01% 5991

Other funds holding LBRX

Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Trails Edge Capital Partners
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Commodore Capital
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
TCG Crossover Management
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Caligan Partners
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Morgan Stanley's LBRX Position: Q2 2026 in Review

Morgan Stanley increased its LB Pharmaceuticals (LBRX) stake by 8.3% in Q2 2026, buying an estimated $115K and bringing the position to 51,207 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #4946.

Morgan Stanley first reported a position in LBRX in Q3 2025 and has held it in 4 quarters since. 114 funds tracked by Wall St. Rank hold LBRX as of Q2 2026.

  • Morgan Stanley held 51,207 shares of LB Pharmaceuticals worth $1.66M as of Q2 2026.
  • Morgan Stanley bought 3,927 LB Pharmaceuticals shares in Q2 2026, an estimated $115K.
  • LB Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #4946 holding.
  • Morgan Stanley first reported a position in LB Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 114 funds tracked by Wall St. Rank held LB Pharmaceuticals as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.